Tagdulang, Christine F.

HRN: 22 23 70  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2023
CEFTRIAXONE 1G (VIAL)
03/06/2023
03/13/2023
IV
1g
Q12
UTI
Waiting Final Action 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines

 Final appropriateness: Yes     

 Overall appropriateness: Yes